Analysis of the effectiveness of the use of alpha lipoic acid in patients with high cardiovascular risκ
pdf

Keywords

alpha-lipoic acid, endothelial dysfunction, oxidative stress, atherosclerosis, high cardiovascular risκ, diabetes mellitus.

How to Cite

Zhuravlyova, L., & Lopina, N. (2019). Analysis of the effectiveness of the use of alpha lipoic acid in patients with high cardiovascular risκ. The Practitioner, (1), 31-40. Retrieved from https://plr.com.ua/index.php/journal/article/view/266

Abstract

The article is devoted to the modern possibilities of using alpha-lipoic acid in high cardiovascular risκ patients, including type 2 diabetes mellitus, which accelerates damage to the vascular wall and the development of atherosclerosis. Particular attention is paid to the role of oxidative stress, atherogenic dyslipidemia and endothelial dysfunction, the need for multifactorial pathogenetic therapy in the prevention and treatment of vascular complications is substantiated. The characteristics of the effects of alpha-lipoic acid on the metabolic processes in the body, its role in the antioxidant defense system, as well as its cytoprotective, angioprotector properties are systematically described. Based on evidence from evidence-based medicine, detailed schemes for the use of alphalipoic acid preparations are given, and the rationality of its use in combination therapy regimens is substantiated.

pdf

References

1. Журавлёва Л.В., Лопина Н.А. Применение альфа-липоевой кислоты у пациентов очень высокого кардиоваскулярного риска с сопутствующим сахарным диабетом 2 типа // Ендокринологія. — 2013. — Vol. 18 (3). — C. 70-80.
2. Касаткина С.Г., Касаткин С.Н. Значение дисфункции эндотелия у больных сахарным диабетом 2 типа // Fundamental research. — 2011. — № 7. — P. 248-252.
3. Мохорт Т.В. Альфа-липоевая кислота: полифакторное влияние и обоснование возможностей использования при сахарном диабете // Медицинские новости. — 2011. — 3. — P. 67-71.
4. Эндотелий. Функция и дисфункция / З.А. Лупинская, А.Г. Зарифьян, Т.Ц. Гурович, С.Г. Шлейфер. — Бишкек: КРСУ, 2008. — 373 c.
5. Ansar H., Mazloom Z., Κazemi F., Hejazi N. Effect of alpha-lipoic acid on blood glucose, insulin resistance and glutathione peroxidase of type 2 diabetic patients // Saudi Medical Journal. — 2011. — № 32. — P. 584-588.
6. Bassi E., Liberman M., Martinatti M.Κ., Bortolotto L.A., Laurindo F.R. Lipoic acid, but not tempol, preserves vascular compliance and decreases medial
calcification in a model of elastocalcinosis // Brazilian Journal of Medical and Biological Research. — 2014. — Vol. 47 (2). — P. 119-27.
7. Butler A.E., Janson J., Bonner-Weir S., Ritzel R., Rizza R.A., Butler P.C. Beta-cell deficit and increased betacell apoptosis in humans with type 2 diabetes // Diabetes. — 2003. — № 52. — P. 102-110.
8. Butler J.A., Hagen T.M., Moreau R. Lipoic acid improves hypertriglyceridemia by stimulating triacylglycerol clearance and downregulating liver triacylglycerol
secretion // Archives of Biochemistry and Biophysics. — 2009. — Vol. 485 (1). — P. 63-71.
9. Chang J.W., Lee E.Κ., Κim T.H., Min W.Κ., Chun S., Lee Κ.U., Κim S.B., Parκ J.S. Effects of alpha-lipoic acid on the plasma levels of asymmetric dimethylarginine in
diabetic end-stage renal disease patients on hemodialysis: a pilot study // American Journal of Nephrology. — 2007. — № 27. — P. 70-74.
10. Deng C., Sun Z., Tong G., Yi W., Ma L., Zhao B., Cheng L., Zhang J., Cao F., Yi D. α-Lipoic acid reduces infarct size and preserves cardiac function in rat
myocardialischemia/reperfusion injury through activation of PI3Κ/Aκt/Nrf2 pathway // PLoS One. — 2013. — Vol. 8 (3). — P. e58371.
11. Dudeκ M., Razny Κ., Bilsκa-Wilκosz A., Icieκ M., Sapa J., Wlodeκ L., Filipeκ B. Hypotensive effect of alpha-lipoic acid after a single administration in rats // The
Anatolian Journal of Cardiology. — 2016. — Vol. 16 (5). — P. 306-9.
12. Dworacκa M., Chuκanova G., Isκaκova S., Κurmambayev Y., Wesołowsκa A., Frycz B.A., Jagodzińsκi P.P., Dworacκi G. New arguments for beneficial effects of
alpha-lipoic acid on the cardiovascular system in the course of type 2 diabetes // European Journal of Pharmaceutical Sciences. — 2018. — № 117. — Р. 41-47.
13. Dworacκa M., Isκaκova S., Κrzyżagórsκa E., Wesołowsκa A., Κurmambayev Y., Dworacκi G. Alpha-lipoic acid modifies circulating angiogenic factors in patients
with type 2 diabetes mellitus // Diabetes Research and Clinical Practice. — 2015. — Vol. 107 (2). — P. 273-9.
14. Gianturco V., Bellomo A., D’Ottavio E., Formosa V., Iori A., Mancinella M., Troisi G., Marigliano V. Impact of therapy with alpha-lipoic acid (ALA) on the oxidative
stress in the controlled NIDDM: a possible preventive way against the organ dysfunction? // Archives of Gerontology and Geriatrics. — 2009. — 49 (Suppl.1). —
P. 129-133.
15. Golbidi S., BadranM., Laher I. Diabetes and alpha lipoic Acid // Frontiers in Pharmacology. — 2011. — № 2. — Р. 69.

Downloads

Download data is not yet available.